Hinweis-Modus ist eingeschaltet Ausschalten

SBIO - Invesco NASDAQ Biotech UCITS ETF Acc (USD) (IE00BQ70R696)

The comparsion limit has been reached: only 5 tools has been added. To add a new one, please remove one of the existing tools.
 
(%)
IE00BQ70R696
SBIO ISIN
Exchange Traded Funds (ETF)
Fondstyp
Invesco
Anbieter
67,16 USD
NAV pro Aktie | 20/07/2026
06/11/2014
Startdatum
Nein
Ausschüttung von Dividenden
CEOGMS
CFI
SBIO
Ticker
Formed
Status
Equity
Investitionsobjekt
Biotech
Sektor
USA
Geographie
NASDAQ Biotechnology Index
Benchmark
0.4 %
Gesamtkostenquote
480,45 Mio. USD
Gesamtes Fondsvermögen | 20/07/2026
480,45 Mio. USD
Aktien-Anlageklasse Volumen | 20/07/2026
Ja
UCITS

Letzte Daten zum
Zum Vergleichen hinzufügen

Kurse (SBIO)

Entdecken Sie die umfangreichste Datenbank

1 000 000

Anleihen weltweit

100 000

Aktien

175 910

ETF & Funds

100 000

Indizes

Verwalten Sie Ihr Portfolio auf effizienteste Weise

  • Bond-Screener
  • Watchlist
  • Excel-Add-In

Kurs-Dynamik

SBIO profile

The Invesco NASDAQ Biotech UCITS ETF Acc (USD) is a(n) Equity Exchange Traded Funds (ETF) seeks to invest in Biotech sector located in USA. The Invesco fund’s base currency is USD and the share class was registered 06.11.2014 with unique ISIN - IE00BQ70R696. Main exchange is London S.E. (USD) and ticker symbol is SBIO. The total expense ratio is 0.4%. The Invesco NASDAQ Biotech UCITS ETF Acc (USD) pays dividends 0 time(s) per year.

Struktur SBIO auf 20/07/2026

Wertpapier Wertpapier
AMGEN ORD 8,13%
VERTEX PHARMACEUTICALS ORD 8,07%
GILEAD SCIENCES ORD 7,45%
REGENERON PHARMACEUTICALS ORD 4,96%
REVOLUTION MEDICINES ORD 2,75%
ALNYLAM PHARMACEUTICALS ORD 2,61%
BIOGEN ORD 2,12%
ILLUMINA ORD 2%
ROYALTY PHARMA CL A ORD 1,82%
ROIVANT SCIENCES ORD 1,76%
MODERNA ORD 1,69%
ARGENX ADR REP ORD 1,67%
INSMED ORD 1,66%
INCYTE ORD 1,66%
UNITED THERAPEUTICS ORD 1,61%
VIATRIS ORD 1,42%
GUARDANT HEALTH ORD 1,41%
NEUROCRINE BIOSCIENCES ORD 1,25%
BRIDGEBIO PHARMA ORD 1,13%
ASCENDIS PHARMA ORD 1,11%
JAZZ PHARMACEUTICALS ORD 1,1%
MEDPACE HOLDINGS ORD 1,08%
EXELIXIS ORD 1%
MADRIGAL PHARMACEUTI ORD 0,89%
BIOMARIN PHARMACEUTICAL ORD 0,82%
AXSOME THERAPEUTICS ORD 0,82%
CYTOKINETICS ORD 0,77%
BIONTECH SE ADR 0,77%
SUMMIT THERAPEUTICS ORD 0,75%
BEONE MEDICINES ADS REP ORD 0,74%
SANOFI 2 ADR REP ORD 0,73%
ARROWHEAD PHARMACEUTICALS ORD 0,72%
KRYSTAL BIOTECH ORD 0,72%
HALOZYME THERAPEUTICS ORD 0,66%
KYMERA THERAPEUTICS ORD 0,65%
CRINETICS PHARMACEUTICALS ORD 0,63%
IONIS PHARMACEUTICALS ORD 0,63%
PROTAGONIST THERAPEUTICS ORD 0,62%
ALKERMES ORD 0,62%
PRAXIS PRECISION MEDICINES ORD 0,61%
SPYRE THERAPEUTICS ORD 0,61%
TEMPUS AI CL A ORD 0,61%
APOGEE THERAPEUTICS ORD 0,6%
IMMUNOVANT ORD 0,59%
VAXCYTE ORD 0,57%
IMMUNITYBIO ORD 0,56%
ABIVAX SA ADR 0,55%
RHYTHM PHARMACEUTICALS ORD 0,51%
MIRUM PHARMACEUTICALS ORD 0,51%
COGENT BIOSCIENCES ORD 0,47%
PTC THERAPEUTICS ORD 0,46%
XENON PHARMACEUTICALS ORD 0,46%
CG ONCOLOGY ORD 0,44%
SCHOLAR ROCK HOLDING ORD 0,44%
LIGAND PHARMACEUTICALS ORD 0,42%
ERASCA ORD 0,42%
AMNEAL PHARMACEUTICALS CL A ORD 0,4%
ORUKA THERAPEUTICS ORD 0,4%
TWIST BIOSCIENCE ORD 0,39%
TRAVERE THERAPEUTICS ORD 0,37%
10X GENOMICS CL A ORD 0,36%
INDIVIOR PHARMACEUTICALS ORD 0,34%
DEFINIUM THERAPEUTICS ORD 0,33%
VERACYTE ORD 0,33%
CRISPR THERAPEUTICS ORD 0,32%
CARIS LIFE SCIENCES ORD 0,32%
ACADIA PHARMACEUTICALS ORD 0,31%
EDGEWISE THERAPEUTICS ORD 0,3%
RELAY THERAPEUTICS ORD 0,29%
TANGO THERAPEUTICS ORD 0,29%
DYNE THERAPEUTICS ORD 0,28%
STRUCTURE THERAPEUTICS ADR 0,26%
DENALI THERAPEUTICS ORD 0,26%
ADAPTIVE BIOTECHNOLOGIES ORD 0,25%
NEWAMSTERDAM PHARMA ORD 0,25%
ALUMIS ORD 0,25%
ARCUTIS BIOTHERAPEUTICS ORD 0,25%
ENLIVEN THERAPEUTICS ORD 0,23%
IDEAYA BIOSCIENCES ORD 0,22%
GRAIL ORD 0,21%
KINIKSA PHARMACEUTICALS INT CL A ORD 0,21%
MBX BIOSCIENCES ORD 0,21%
DISC MEDICINE ORD 0,2%
ULTRAGENYX PHARMACEUTICAL ORD 0,2%
SUPERNUS PHARMACEUTICALS ORD 0,2%
BEAM THERAPEUTICS ORD 0,19%
VERA THERAPEUTICS CL A ORD 0,19%
ATAIBECKLEY ORD 0,19%
KODIAK SCIENCES ORD 0,18%
UNIQURE ORD 0,18%
TARSUS PHARMACEUTICALS ORD 0,17%
AGIOS PHARMACEUTICALS ORD 0,17%
TREVI THERAPEUTICS ORD 0,17%
NURIX THERAPEUTICS ORD 0,17%
PHARVARIS N V ORD 0,17%
VERICEL ORD 0,17%
BIOCRYST PHARMACEUTICALS ORD 0,17%
IOVANCE BIOTHERAPEUTICS ORD 0,16%
MINERALYS THERAPEUTICS ORD 0,16%
GENMAB ADR 0,15%
Andere - %

Andere ETFs und Fonds dieses Anbieters

Ähnliche Etf & Fonds

  • {{ item.etf.ttl }}
    {{ item.nav_usd }} Mio.
    NAV
    {{ item.expense_ratio }}
    Gesamtkostenquote
Sie müssen sich registrieren , um Zugriff zu erhalten.